-
Inspira Technologies completes clinical study for HYLA blood sensor
-
Inspira Technologies submits ART100 system for UAE regulatory approval
-
Inspira Technologies partners with Bites for AI training integration
-
Inspira Technologies names former J&J manager as VP of global sales
-
Inspira Technologies names former J&J exec as VP of global sales
-
Inspira Technologies reports 97.3% accuracy for HYLA blood sensor
-
Innovation and IP in Medtech Stocks - How Patents Build Leaders
-
Inspira Technologies receives US patent for ART500 core technology
-
Inspira Technologies secures $27 million government order for ART100 systems
-
Inspira Technologies calls “routine” its filing of shelf registration renewal
-
Inspira Technologies hires consulting firm for strategic initiatives
-
Inspira Technologies (IINN) in talks with foreign government on ART100 distribution
-
Inspira Technologies (IINN) Secures $22.5M Purchase Order, Launches Full Revenue Execution Phase
-
Inspira Technologies (IINN) Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority
-
Litchfield Hills Research Starts Inspira Technologies (IINN) at Buy
-
Inspira Technologies (IINN) Initiates Global Commercial Rollout of ART100 System
-
Inspira Technologies (IINN) Aligns Executive Team Amid Corporate Structuring Initiatives
-
Inspira Technologies (IINN): ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients
-
Inspira Technologies (IINN) Generates First Revenues from Deployment of INSPIRA ART100 Systems
-
Inspira Technologies (IINN) Releases CEO Update
-
Inspira Technologies (IINN) Receives Nasdaq Non-compliance
-
Inspira Technologies (IINN) Achieves Positive Results of Above 95% For Preventing Bloodstream Infections
-
Inspira Technologies (IINN) Collaborates With Zriha Medical To Launch Cutting-Edge Production Line
-
Inspira Technologies (IINN) Preparing Production in Response to Spread of Respiratory Virus in China
-
Inspira Technologies (IINN) Prices 4.61M Share Offering at $0.70/sh
-
Inspira Technologies (IINN) Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA ART100
-
Inspira Technologies (IINN) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
-
Inspira Technologies (IINN) Secures a Second U.S. Patent Approval
-
Inspira Technologies (IINN) to Publish HYLA Clinical Results in Fourth Quarter 2024
-
Inspira Technologies (IINN) Announces FDA Listing and Market Readiness of New Product
-
Inspira Technologies (IINN) Israeli Regulatory Approval for the INSPIRA ART100 System
-
Inspira Technologies (IINN) Announces Business Plan Targets
-
Inspira Technologies (IINN) Receives First Ever US Purchase Order for INSPIRA ART100 Systems

